Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.110
0.00 (0.00%)
At close: Dec 19, 2025, 4:00 PM EST
1.120
+0.010 (0.90%)
After-hours: Dec 19, 2025, 7:58 PM EST
Humacyte Employees
As of December 31, 2024, Humacyte had 220 total employees, including 218 full-time and 2 part-time employees. The number of employees increased by 35 or 18.92% compared to the previous year.
Employees
220
Change (1Y)
35
Growth (1Y)
18.92%
Revenue / Employee
$7,141
Profits / Employee
-$168,041
Market Cap
207.87M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 220 | 35 | 18.92% |
| Dec 31, 2023 | 185 | 21 | 12.80% |
| Dec 31, 2022 | 164 | 18 | 12.33% |
| Dec 31, 2021 | 146 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HUMA News
- 3 days ago - Humacyte Announces Credit Facility of Up to $77.5 Million with Avenue Capital - GlobeNewsWire
- 4 weeks ago - Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Acellular Tissue Engineered Vessel (ATEV™) Clinical Results - GlobeNewsWire
- 5 weeks ago - Humacyte Announces Six Presentations Scheduled for the Upcoming 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium) - GlobeNewsWire
- 5 weeks ago - Humacyte, Inc. (HUMA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Humacyte Announces Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Humacyte Announces Presentation of Positive Two-Year Results from Phase 3 Dialysis Access Trial at the American Society of Nephrology's Kidney Week 2025 - GlobeNewsWire
- 6 weeks ago - Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025 - GlobeNewsWire
- 7 weeks ago - Humacyte Announces Publication of New Data Comparing Symvess™ to Autologous Vein in Extremity Arterial Trauma - GlobeNewsWire